⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Consult your healthcare provider before starting any medication or making changes to your current treatment plan.
You are midway through your third month on Ozempic. Your HbA1c has dropped, you are losing weight steadily, and the side effects have finally settled. Then your chemist tells you: stock unavailable. Come back next month.
This scenario is common in India. GLP-1 medications — particularly injectable semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) — are imported and subject to global supply constraints, distribution delays, and sudden demand surges. When a new study makes news or a celebrity endorses a medication, chemists across Delhi and Mumbai can run out within days.
This guide covers exactly what Indian patients should do when their GLP-1 medication is unavailable — and, more importantly, what they should NOT do.
Understanding why shortages occur helps you anticipate and plan for them.
Global manufacturing constraints: Semaglutide and tirzepatide are biologics that require sophisticated manufacturing. Novo Nordisk and Eli Lilly have significantly expanded production, but global demand — driven largely by markets in the US and Europe — still outpaces supply in some periods.
India's import dependency: India does not currently manufacture semaglutide or tirzepatide domestically. All injectable GLP-1 products are imported, making them vulnerable to:
Grey market and diversion: When shortages occur in official channels, unregulated supplies appear through informal pharmacies, social media sellers, and WhatsApp groups. These may be counterfeit, improperly stored, or illegally diverted from other markets.
Demand spikes: GLP-1 media coverage in India is intense in 2025. Every major magazine and influencer feature on "Ozempic for weight loss" creates a demand surge that supply chains cannot immediately meet.
Before planning around a shortage, it is important to understand the clinical consequences of missing GLP-1 doses — which are less dramatic than many patients fear.
Short gap (1–2 weeks): GLP-1 medication effects are sustained by steady blood levels of the drug. Semaglutide has a half-life of approximately 1 week, meaning blood levels drop by half each week after stopping. A 1–2 week gap usually means gradual return of appetite, possibly some weight regain (mostly water and glycogen), and modest glucose rises in diabetic patients. It is not a medical emergency for most people.
Longer gap (3–6 weeks): Gut receptor sensitivity to GLP-1 partially resets. When you restart, you should retitrate from a lower dose, not resume at your current dose.
Gap of more than 6 weeks: Significant return of pre-treatment appetite, potential weight regain, HbA1c rise in diabetics. Restart from the beginning of the titration schedule.
For patients using GLP-1 primarily for Type 2 diabetes management, a prolonged gap requires immediate contact with your prescriber to adjust alternative medications (metformin, DPP-4 inhibitors, SGLT2 inhibitors) to maintain glycaemic control.
Before assuming Ozempic is unavailable, check:
Do not wait for your next scheduled appointment. Call or message your doctor's clinic and explain the shortage. Your doctor needs to know so they can:
If injectable semaglutide is unavailable, oral semaglutide (Rybelsus) may be in stock — check with your pharmacist. The two are not equivalent in dose or bioavailability, but transitioning temporarily under medical supervision is possible.
Note: Rybelsus is typically available at 3 mg, 7 mg, and 14 mg tablets and requires specific administration instructions (empty stomach, 30 minutes before food).
If you are on injectable semaglutide primarily for Type 2 diabetes, your doctor may temporarily bridge with a DPP-4 inhibitor (sitagliptin, vildagliptin) or SGLT2 inhibitor (empagliflozin, dapagliflozin) while waiting for stock.
This deserves emphasis. During shortages, counterfeit GLP-1 medications circulate in India through:
Counterfeit semaglutide has been documented globally. It may contain wrong concentrations, no active ingredient, or dangerous contaminants. The savings are not worth the risk. Buy only from licensed pharmacies that dispense against a valid prescription.
A gap in medication does not erase the progress you have made. However, appetite will return, often abruptly after 1–2 weeks off GLP-1. This is the critical window where habits matter.
Gap of less than 2 weeks: Resume at your previous dose.
Gap of 2–4 weeks: Resume one dose step below your previous dose (e.g., if you were on 1 mg Ozempic, restart at 0.5 mg for 4 weeks before going back to 1 mg).
Gap of more than 4 weeks: Restart from the beginning of the titration schedule (0.25 mg semaglutide or 2.5 mg tirzepatide). Skipping the retitration phase will cause significant nausea.
This is not a setback — it is the clinically correct approach.
Buying medications from social media sellers or grey market sources Already discussed — this is the most dangerous mistake. Documented cases of counterfeit insulin and GLP-1 products in India have caused hypoglycaemia, allergic reactions, and ICU admissions.
Doubling up the next dose to "make up for" missed doses Never take double doses of GLP-1 medication. A double dose dramatically increases nausea and vomiting risk and can cause dangerous hypoglycaemia if you are also on insulin.
Abruptly stopping all other diabetes medications during the gap If you stopped metformin or other oral hypoglycaemics when starting GLP-1, do not restart them without medical guidance. Dosing needs to be recalibrated.
Panicking and ordering untested alternatives online Herbal "GLP-1 mimics," berberine supplements, and other products marketed as alternatives during shortages are not equivalent to semaglutide or tirzepatide. They do not carry the same evidence base. Some may interact with your other medications.
Request a 2-month prescription when stock is available Many prescribers in India write monthly prescriptions. Ask your doctor if a 2-month supply is appropriate for your situation — this gives you a buffer if shortages occur.
Sign up for stock alerts on pharmacy apps PharmEasy, Tata 1mg, and Netmeds have in-stock notification features. Register your email for alerts when your specific product becomes available.
Build a 2-week emergency reserve gradually If your prescription allows it, always keeping one unused pen/cartridge means a 1–2 week supply disruption does not immediately affect your treatment.
Stay connected with your prescriber Doctors with high GLP-1 patient volumes often know about supply issues before chemists do and may have access to restocks earlier.
Q: I missed 3 weeks of Ozempic due to shortage. My HbA1c was 7.8% before starting. Is this dangerous?
Call your doctor today. Three weeks off semaglutide will raise your blood sugar noticeably. Your doctor may temporarily adjust other medications or advise dietary modifications until Ozempic is back in stock.
Q: Can I use Rybelsus as a substitute for Ozempic?
Only under your doctor's guidance. The dose conversion is complex, and Rybelsus has different bioavailability and administration requirements. It is not a straightforward swap.
Q: My seller on Instagram has Ozempic at half price. Is it safe?
No. There is no regulated supply pathway from Instagram sellers. This is either counterfeit, diverted, improperly stored, or expired. Do not purchase.
Q: Does a 2-week break completely undo my progress?
No. The metabolic improvements from GLP-1 (improved insulin sensitivity, reduced liver fat, cardiovascular benefits) persist beyond the medication. A brief gap causes some temporary appetite return and possible minor weight fluctuation — it does not erase months of progress.
Consult your healthcare provider before starting any medication or making changes to your treatment plan. This guide is informational only and does not replace medical advice.
